The following is an excerpt from Ophthalmology Times, originally published the week of December 15, 2012.
Sightpath Medical launches refractive cataract service in 2013
Bloomington, MN– Sightpath Medical announces the launch of its refractive cataract service (MoFe) in early 2013. This new service will include a femtosecond laser and an intraoperative wavefront aberrometer, as well as a certified laser engineer on a per-procedure basis to deliver on the expectation of a planned visual outcome for physicians and patients.
In 2007, Sightpath Medical was formed with the union of Midwest Surgical Services (MSS) and Laser Vision Centers Inc. (LVCI), both of whom were leaders in the cataract and refractive surgery categories since beginning in 1991, noted Jim Tiffany, president and chief executive officer, Sightpath Medical.
These two companies offered their on-demand services to facilities, surgeons, and their patients at a time when expensive, new technology was entering the market and surgical volumes were on the rise, he said.
“I have had the good fortune of spending nearly 30 years in the ophthalmology market and the last 12 with LVCI, MSS, and Sightpath,” TIffany said. “This is a rare convergence of market forces and company expertise leading to an opportunity to offer a new service in an affordable manner.”
Sightpath Medical’s patented air-ride system, currently used to mobilize a fleet of more than 200 femtosecond, excimer, Wavescan, and YAG and SLT lasers, coupled with a full staff of certified laser engineers and technicians, offers surgeons technical expertise, clinical reliability, and proven performance standards second to none, he said.